Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48.9M
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
3.83M
-
Shares change
-
+311K
-
Total reported value, excl. options
-
$10.8M
-
Value change
-
+$479K
-
Put/Call ratio
-
0.22
-
Number of buys
-
16
-
Number of sells
-
-19
-
Price
-
$2.82
Significant Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q4 2018
47 filings reported holding AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q4 2018.
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.83M shares
of 48.9M outstanding shares and own 7.82% of the company stock.
Largest 10 shareholders include Alethea Capital Management, LLC (908K shares), STIFEL FINANCIAL CORP (404K shares), Sio Capital Management, LLC (381K shares), Vanguard Group Inc (339K shares), ROYCE & ASSOCIATES LP (332K shares), MILLENNIUM MANAGEMENT LLC (309K shares), Point72 Asset Management, L.P. (250K shares), Endurant Capital Management LP (209K shares), GEODE CAPITAL MANAGEMENT, LLC (94.2K shares), and JACOBS LEVY EQUITY MANAGEMENT, INC (84.2K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.